Paul Tudor Jones Macrogenics Inc Transaction History

Tudor Investment Corp Et Al

$26.8 Billion
Q3 2024

A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Macrogenics Inc stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 31,193 shares of MGNX stock, worth $101,689. This represents 0.0% of its overall portfolio holdings.

Number of Shares

31,193

Holding current value

$101,689

% of portfolio

0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$3.0 - $5.55 $93,579 - $173,121	31,193 New	31,193 $102,000
Q3 2023 Nov 15, 2023	BUY	$4.48 - $6.19 $1,720 - $2,376	384 Added 0.28%	139,080 $648,000
Q2 2023 Aug 14, 2023	BUY	$4.62 - $7.54 $373,111 - $608,930	80,760 Added 139.4%	138,696 $742,000
Q1 2023 May 15, 2023	BUY	$4.82 - $7.24 $129,084 - $193,894	26,781 Added 85.96%	57,936 $415,000
Q4 2022 Feb 14, 2023	SELL	$3.34 - $6.98 $298,823 - $624,486	-89,468 Reduced 74.17%	31,155 $209,000
Q3 2022 Nov 14, 2022	SELL	$3.01 - $5.22 $101,461 - $175,955	-33,708 Reduced 21.84%	120,623 $417,000
Q2 2022 Aug 15, 2022	BUY	$2.25 - $9.99 $2,925 - $12,987	1,300 Added 0.85%	154,331 $455,000
Q1 2022 May 16, 2022	BUY	$8.12 - $16.9 $818,991 - $1.7 Million	100,861 Added 193.33%	153,031 $1.35 Million
Q4 2021 Feb 14, 2022	BUY	$15.91 - $21.88 $830,024 - $1.14 Million	52,170 New	52,170 $837,000
Q3 2021 Nov 15, 2021	SELL	$19.74 - $28.7 $513,358 - $746,372	-26,006 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$20.49 - $35.63 $373,778 - $649,962	18,242 Added 234.96%	26,006 $699,000
Q1 2021 May 17, 2021	SELL	$18.99 - $33.2 $2.44 Million - $4.26 Million	-128,321 Reduced 94.29%	7,764 $247,000
Q4 2020 Feb 16, 2021	BUY	$19.41 - $26.0 $2.64 Million - $3.54 Million	136,085 New	136,085 $3.11 Million
Q3 2020 Nov 16, 2020	SELL	$24.69 - $31.6 $227,320 - $290,941	-9,207 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$5.2 - $29.12 $47,876 - $268,107	9,207 New	9,207 $257,000
Q1 2020 May 15, 2020	SELL	$4.28 - $12.11 $127,441 - $360,587	-29,776 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$7.95 - $12.27 $236,719 - $365,351	29,776 New	29,776 $324,000
Q1 2019 May 15, 2019	SELL	$11.11 - $25.6 $246,630 - $568,294	-22,199 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$11.75 - $21.42 $35 - $64	-3 Reduced 0.01%	22,199 $282,000
Q3 2018 Nov 14, 2018	SELL	$19.26 - $23.46 $5,893 - $7,178	-306 Reduced 1.36%	22,202 $476,000
Q2 2018 Aug 14, 2018	SELL	$19.78 - $24.67 $327,438 - $408,387	-16,554 Reduced 42.38%	22,508 $465,000
Q1 2018 May 15, 2018	BUY	$18.89 - $32.46 $464,618 - $798,386	24,596 Added 170.03%	39,062 $983,000
Q4 2017 Feb 14, 2018	SELL	$16.19 - $20.3 $90,064 - $112,928	-5,563 Reduced 27.77%	14,466 $275,000
Q3 2017 Nov 14, 2017	BUY	$15.52 - $18.94 $310,850 - $379,349	20,029	20,029 $370,000

Others Institutions Holding MGNX

# of Institutions

132

Shares Held

55.4M

Call Options Held

215K

Put Options Held

238K

View Full List

About MACROGENICS INC

Ticker MGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,458,800
Market Cap $200M
Description
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...

More about MGNX

Track Paul Tudor Jones's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.

Account